Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

First Line Gefitinib by FDG-PET Metabolic Response

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2013 by Asan Medical Center.
Recruitment status was:  Recruiting
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Sang-We Kim, Asan Medical Center
ClinicalTrials.gov Identifier:
NCT01510990
First received: January 10, 2012
Last updated: January 26, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: November 2015
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)